AUS
NZ
UK
CA
USA
IND
Healthcare
Alcidion’s Healthcare Expansion Signals Digital Growth
May 18, 2026 05:49 PM AEST| By SamAlcidion expands its healthcare technology capabilities through a strategic acquisition, enhancing patient flow solutions, customer reach, and cloud-based healthcare innovation across Australia.
Why Pro Medicus Is Defying the Market Mood
May 18, 2026 04:23 PM AEST| By SamPro Medicus drew attention after securing a major healthcare imaging agreement in North America, reinforcing confidence around digital healthcare infrastructure and cloud-based enterprise imaging technology despite broader market weakness.
Why Pro Medicus Has the Market Watching Closely
May 18, 2026 03:45 PM AEST| By SamPro Medicus has strengthened its global healthcare technology presence through another major imaging agreement, highlighting rising demand for cloud-based medical infrastructure and enterprise diagnostic platforms.
Why This Hearing Giant’s Slump Is Turning Heads
May 18, 2026 03:29 PM AEST| By SamCochlear’s recent market decline has shifted attention toward its long-term healthcare strengths, specialised hearing technology, and growing global treatment demand despite softer market sentiment.
ASX 20 Healthcare Giant Draws Attention After Sharp Share Price Slide
May 18, 2026 10:56 AM AEST| By SamCSL remains under strong investor focus as biotechnology growth, healthcare demand, and defensive earnings themes continue shaping market sentiment.
ASX 200 Healthcare Share Faces Pressure After Guidance Reset
May 18, 2026 10:20 AM AEST| By SamHealius remains under market scrutiny as labour cost inflation, healthcare funding pressures, and operational restructuring reshape sentiment around the healthcare provider.
Could Integral Diagnostics ASX 300 Stay In Focus?
May 18, 2026 10:19 AM AEST| By SamIntegral Diagnostics remained under healthcare market attention as diagnostic imaging demand, connected healthcare systems and digital patient support platforms continued shaping Australia’s medical technology sector.
Could ResMed ASX 200 Healthcare Strength Continue?
May 17, 2026 05:33 PM AEST| By SamResMed remained under healthcare market attention as respiratory treatment systems, sleep care technologies and connected healthcare platforms continued shaping Australia’s medical technology sector.
Radiopharm Theranostics Draws Attention After Insider Buying
May 17, 2026 10:46 AM AEST| By SamRadiopharm Theranostics continues attracting market attention as insider buying activity and growing interest in precision oncology shape sentiment around the emerging healthcare company.
Why Cochlear Is Quietly Regaining Market Attention
May 17, 2026 10:43 AM AEST| By SamCochlear continues attracting investor attention as healthcare stocks regain momentum through defensive demand trends, ageing population exposure, and long-term medical technology growth themes.
Why ResMed Shares Are Back in Focus Amid Healthcare Technology Shifts
May 16, 2026 01:15 PM AEST| By SamResMed and QBE are drawing renewed attention as healthcare technology adoption, ageing populations, and financial resilience continue shaping long-term ASX market trends.
Healthy Chef Expands Nationwide With Priceline Partnership
May 15, 2026 03:54 PM AEST| By SamElixinol Wellness expands The Healthy Chef into Priceline stores across Australia, boosting wellness retail exposure and strengthening its position in the growing nutrition market.
ASX Healthcare Sector Faces Renewed Market Pressure
May 15, 2026 03:50 PM AEST| By SamASX healthcare shares witnessed heightened volatility as major companies revised earnings outlooks, while innovative medical technology firms continued expanding commercial opportunities in global healthcare markets.
ASX Healthcare Share Pushes Ahead With RC220 Trial
May 15, 2026 03:17 PM AEST| By SamRacura Oncology advanced its RC220 clinical trial after receiving approval for higher dosage levels, highlighting growing momentum across Australia’s biotechnology and oncology research sector.
Pacific Edge Expands Funding Base as Healthcare Competition Intensifies
May 15, 2026 02:56 PM AEST| By SamPacific Edge expanded its capital base as diagnostics innovation and healthcare technology transformation continued reshaping medical testing markets.
Why Anteris Technologies Is Drawing Attention Despite Cash Burn Concerns
May 15, 2026 02:48 PM AEST| By SamAnteris Technologies remained in focus as strong liquidity and healthcare innovation themes supported attention toward its cardiovascular technology development strategy.
Telix Pharma Expands Imaging Focus Across Cancer Care
May 15, 2026 02:46 PM AEST| By SamTelix Pharmaceuticals expands its cancer imaging portfolio with kidney and brain diagnostic advancements, strengthening its healthcare market presence and drawing attention across the biotechnology sector.
Why Anteris Technologies Is Drawing Attention Despite Cash Burn
May 15, 2026 11:03 AM AEST| By SamAnteris Technologies remained in focus as investors weighed its cash runway, cardiovascular innovation strategy, and long-term positioning within the evolving global medtech sector.
ASX 200 Biotech Sector Watch Amid Healthcare Market Activity
May 15, 2026 10:33 AM AEST| By SamAustralian biotechnology stocks remained under market attention as healthcare innovation, medical research participation, and clinical development activity continued shaping broader healthcare sector operations.
Why ASX Functional Beverage Stocks Are Gaining Momentum
May 15, 2026 10:24 AM AEST| By SamASX-listed beverage companies are capitalising on rising demand for wellness drinks, hydration products, protein beverages, and alcohol alternatives as health-conscious consumer behaviour reshapes the global drinks industry.
Advertise your brand on Kalkine Media